Another piece of the AML puzzle

摘要

In this issue of Blood, Coenen et al report on a subset of pediatric acute myeloid leukemia (AML) with t(8;16)(p11;p13)/MYST3-CREBBP rearrangement demonstrating specific features with respect to cytomorphology and gene expression patterns, thus fulfilling the criteria of a distinct biological disease entity according to the World Health Organization (WHO) classification.